WebSep 21, 2024 · Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating prote ... TANGO aims to restore missing proteins by ... WebOct 1, 2016 · Stoke’s TANGO platform is a nod to our co-founders Dr. Adrian Krainer & Isabel Aznarez’s native Uruguayan roots. Isa reflects on how her heritage… Liked by Laura Seskevich

Tango Therapeutics

WebNov 8, 2024 · Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. Using the Company’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to … WebJul 9, 2024 · Our approach, termed targeted augmentation of nuclear gene output (TANGO), exploits ASO-mediated modulation of naturally occurring non-productive AS events. We … fiona hill durham

Acadia Pharmaceuticals and Stoke Therapeutics Announce …

WebJan 26, 2024 · Stoke’s TANGO technology is based on ASOs, which are small fragments of modified RNA designed to bind to specific regions of pre-mRNA, thus reducing non-productive mRNA and boosting protein production. In addition to SCN1A, three other disease-related genes were identified as ASO candidates. WebAug 10, 2024 · As a result of the business combination, Tango Therapeutics expects to receive gross proceeds of approximately $342 million, which consists of cash proceeds of approximately $156 million from BCTG ... fiona hill book there is nothing for you here